Last reviewed · How we verify
Treatment E- Fexofenadine HCl 120mg — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Treatment E- Fexofenadine HCl 120mg (Treatment E- Fexofenadine HCl 120mg) — Sen-Jam Pharmaceutical.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Treatment E- Fexofenadine HCl 120mg TARGET | Treatment E- Fexofenadine HCl 120mg | Sen-Jam Pharmaceutical | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Treatment E- Fexofenadine HCl 120mg CI watch — RSS
- Treatment E- Fexofenadine HCl 120mg CI watch — Atom
- Treatment E- Fexofenadine HCl 120mg CI watch — JSON
- Treatment E- Fexofenadine HCl 120mg alone — RSS
Cite this brief
Drug Landscape (2026). Treatment E- Fexofenadine HCl 120mg — Competitive Intelligence Brief. https://druglandscape.com/ci/treatment-e-fexofenadine-hcl-120mg. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab